Bruno O. Villoutreix

Inserm UMR 1141, 48 Boulevard Sérurier
Paris, 75019, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

The covalent docking software landscape: features and applications in drug design.

The covalent docking software landscape: features and applications in drug design.

Journal: Briefings in bioinformatics

Published: August 20, 2025

Drug repositioning

Drug repositioning

Journal: La Revue du praticien

Published: December 03, 2024

Editor's Note: Therapeutic Targeting of Nuclear γ-Tubulin in RB1-Negative Tumors.

Editor's Note: Therapeutic Targeting of Nuclear γ-Tubulin in RB1-Negative Tumors.

Journal: Molecular cancer research : MCR

Published: August 23, 2024

Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer.

Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer.

Journal: EMBO molecular medicine

Published: February 08, 2024

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death.

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death.

Journal: Nature communications

Published: January 10, 2024

Discovery, Structure-Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5.

Discovery, Structure-Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5.

Journal: Journal of medicinal chemistry

Published: August 28, 2023

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression.

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression.

Journal: Frontiers in immunology

Published: August 16, 2023

Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.

Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.

Journal: Expert opinion on drug discovery

Published: May 29, 2023

Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.

Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.

Journal: Human genomics

Published: December 31, 2022

A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein-Protein Interfaces.

A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein-Protein Interfaces.

Journal: International journal of molecular sciences

Published: September 28, 2022

Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets.

Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 06, 2022

A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides.

A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides.

Journal: Data in brief

Published: February 09, 2022

Showing 1-12 of 96

Last Updated: 09/26/2026